A common pattern of somatic mutations in t-MDS/AML of patients treated with PARP inhibitors for metastatic ovarian cancer.
Patrizia ChiusoloClaudia MarchettiMonica RossiGessica MinnellaVanda SalutariMariagrazia DistefanoSabrina GiammarcoElisabetta MetafuniAngelo MinucciFilippo FrioniCristiana GasbarrinoMaria ColangeloDaniela OrteschiAnna FagottiDomenica LorussoLivio PaganoValerio De StefanoGiovanni ScambiaSimona SicaPublished in: American journal of hematology (2022)